Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Cetuximab
Related studies linked through entity extraction aliases.
Chemoembolisation With CPT11 Loaded DC Bead With Cetuximab and 5FU/LV in First Line in Patients With KRAS Wildtype mCRC
- Status
- WITHDRAWN
- Phase
- NA
Phase I Study of Cetuximab in Combination With 5-fluoruracil, Mitomycin C and Radiotherapy in Patients With Anal Cancer Stage T2 (>4 cm) - T4 N0-3 M0 or Any T N2-3 M0
- Status
- COMPLETED
- Phase
- PHASE1
Induction Chemotherapy Followed by Concurrent Radiation With Cetuximab or Cisplatin in Locally Advanced Nasopharyngeal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Combination Chemotherapy, Cetuximab and Radiation for Patients With Localized Gastric Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Trial of Dalotuzumab in Combination With Irinotecan Versus Cetuximab and Irinotecan for Participants With Metastatic Rectal Cancers (mRC) (MK-0646-025)
- Status
- TERMINATED
- Phase
- PHASE2
A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck
- Status
- COMPLETED
- Phase
- PHASE2
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE4
Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease
- Status
- TERMINATED
- Phase
- PHASE1
MLN8237 in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Vemurafenib in Participants With BRAF V600 Mutation-Positive Cancers
- Status
- COMPLETED
- Phase
- PHASE2
Colorectal Cancer (CRC) Cetuximab Elderly Frail
- Status
- TERMINATED
- Phase
- PHASE2
Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin
- Status
- COMPLETED
- Phase
- PHASE1
Treatment Selection According to Skin Reaction to Cetuximab
- Status
- UNKNOWN
- Phase
- PHASE2
Study of ABT-700 in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Cetuximab and Recombinant Interleukin-12 in Treating Patients With Squamous Cell Carcinoma of the Head and Neck That is Recurrent, Metastatic, or Cannot Be Removed by Surgery
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2